Drug Discovery
Cambridge Biotechnology has a world class drug discovery capability with a proven track record from drug-target identification through to early-stage clinical trials. Current programmes include the discovery and development of breakthrough opportunities for the treatment of specialist indications.
Cambridge Biotechnology operates as a highly efficient drug discovery unit with in house expertise in molecular and cell biology, pharmacology, medicinal chemistry, analytical chemistry, pharmacokinetics, computational chemistry and informatics. It works in close collaboration with its parent company in Stockholm which ensures a timely delivery of high value candidate molecules to enter drug development.
|
